Atlas Trials

Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM

Clinical trial NCT04891809 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04891809
Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Newly Diagnosed Multiple Myeloma
Start date
2021-10-20
Primary completion
2027-12-01
Enrollment
198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.